Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.
Mattiuzzi C, Lippi G. Current Cancer Epidemiology glossary. J Epidemiol Glob Health. 2019;9:217–22.
Debien V, De Caluwé A, Wang X, Piccart-Gebhart M, Tuohy VK, Romano E, et al. Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ Breast Cancer. 2023;9:1–10.
Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21:541–57.
Oudkerk M, Liu SY, Heuvelmans MA, Walter JE, Field JK. Lung cancer LDCT screening and mortality reduction—evidence, pitfalls and future perspectives. Nat Rev Clin Oncol. 2021;18:135–51.
Schlumberger M, Leboulleux S. Current practice in patients with differentiated thyroid cancer. Nat Rev Endocrinol. 2021;17:176–88.
Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4:877–92.
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11:e197–206.
Van HLMC, Vrieling A, Van Der HAG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer : challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287–304.
Esmeeta A, Adhikary S, Dharshnaa V, Swarnamughi P, Ummul Maqsummiya Z, Banerjee A, et al. Plant-derived bioactive compounds in colon cancer treatment: an updated review. Biomed Pharmacother. 2022;153: 113384.
Mirza MR, Chase DM, Slomovitz BM, dePont CR, Novák Z, Black D, et al. Dostarlimab for primary advanced or recurrent endometrial cancer. N Engl J Med. 2023;388:2145–58.
Choueiri TK, Albiges L, Atkins MB, Bakouny Z, Bratslavsky G, Braun DA, et al. From basic science to clinical translation in kidney cancer: a report from the second kidney cancer research summit. Clin Cancer Res. 2022;28:831–9.
Rodriguez-Otero P, Ailawadhi S, Arnulf B, Patel K, Cavo M, Nooka AK, et al. Ide-cel or standard regimens in relapsed and refractory multiple myeloma. N Engl J Med. 2023;388:1002–14.
Armitage JO, Long DL. Mantle-cell lymphoma. N Engl J Med. 2022;386:2495–506.
Hingorani SR. Epithelial and stromal co-evolution and complicity in pancreatic cancer. Nat Rev Cancer. 2023;23:57–77.
Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, et al. Zanubrutinib or Ibrutinib in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2023;388:319–32.
Patel SP, Othus M, Chen Y, Wright GP, Yost KJ, Hyngstrom JR, et al. Neoadjuvant–adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med. 2023;388:813–23.
Nakhoda S, Vistarop A, Wang YL. Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma. Br J Haematol. 2023;200:137–49.
Pashayan N, Pharoah PDP. The challenge of early detection in cancer. Science. 1979;2020(368):589–90.
Li X, Bao Y, Li Z, Teng P, Ma L, Zhang H, et al. Employing antagonistic C-X-C motif chemokine receptor 4 antagonistic peptide functionalized NaGdF4 nanodots for magnetic resonance imaging-guided biotherapy of breast cancer. Sci Rep. 2024;14:15764.
Kumar Sarangi M, Padhi S, Rath G, Sekhar Nanda S, Kee YD. Advances in immunological and theranostic approaches of gold nanoparticles—a review. Inorg Chem Commun. 2023;153:110858.
Dutta Gupta Y, Mackeyev Y, Krishnan S, Bhandary S. Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics. Cancer Nanotechnol. 2024;15:1–44.
Hosseini SM, Mohammadnejad J, Salamat S, Beiram Zadeh Z, Tanhaei M, Ramakrishna S. Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review. Mater Today Chem. 2023;29: 101400.
Yukawa H, Sato K, Baba Y. Theranostics applications of quantum dots in regenerative medicine, cancer medicine, and infectious diseases. Adv Drug Deliv Rev. 2023;200:114863.
Ma Q, Cao Y, Ge X, Zhang Z, Gao S, Song J. X-ray excited luminescence materials for cancer diagnosis and theranostics. Laser Photon Rev. 2024;18:2300565.
Al-Thani AN, Jan AG, Abbas M, Geetha M, Sadasivuni KK. Nanoparticles in cancer theragnostic and drug delivery: a comprehensive review. Life Sci. 2024;352: 122899.
Rahimkhoei V, Alzaidy AH, Abed MJ, Rashki S, Salavati-Niasari M. Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics. Adv Colloid Interface Sci. 2024;329: 103204.
Jin GQ, Chau CV, Arambula JF, Gao S, Sessler JL, Zhang JL. Lanthanide porphyrinoids as molecular theranostics. Chem Soc Rev. 2022;51:6177–209.
Domingues I, Pereira G, Martins P, Duarte H, Santos J, Abreu PH. Using deep learning techniques in medical imaging: a systematic review of applications on CT and PET. Artif Intell Rev. 2020;53:4093–160.
Hsu JC, Nieves LM, Betzer O, Sadan T, Noël PB, Popovtzer R, et al. Nanoparticle contrast agents for X-ray imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:1–26.
Wu Q, Zheng Q, He Y, Chen Q, Yang H. Emerging nanoagents for medical x-ray imaging. Anal Chem. 2023;95:33–48.
Sun W, Zhou Z, Pratx G, Chen X, Chen H. Nanoscintillator-mediated X-ray induced photodynamic therapy for deep-seated tumors: from concept to biomedical applications. Theranostics. 2020;10:1296–318.
Yu X, Liu X, Yang K, Chen X, Li W. Pnictogen semimetal (Sb, Bi)-based nanomaterials for cancer imaging and therapy: a materials perspective. ACS Nano. 2021;15:2038–67.
Pires L, Calcada C, Grafinger O, Juneja R, Mar S, Leong H, et al. Photosensitizers as radiosensitizers for metastatic and deep-seated tumors: in vitro and ex-ovo preclinical studies. Photodiagnosis Photodyn Ther. 2023;41: 103422.
Belanova A, Chmykhalo V, Beseda D, Belousova M, Butova V, Soldatov A, et al. A mini-review of X-ray photodynamic therapy (XPDT) nonoagent constituents’ safety and relevant design considerations. Photochem Photobiol Sci. 2020;19:1134–44.
Fan W, Huang P, Chen X. Overcoming the Achilles’ heel of photodynamic therapy. Chem Soc Rev. 2016;45:6488–519.
Chen X, Song J, Chen X, Yang H. X-ray-activated nanosystems for theranostic applications. Chem Soc Rev. 2019;48:3073–101.
Kirakci K, Kubát P, Fejfarova K, Martinčík J, Nikl M, Lang K. X-ray inducible luminescence and singlet oxygen sensitization by an octahedral molybdenum cluster compound: a new class of nanoscintillators. Inorg Chem. 2016;55:803–9.
Lei L, Wang Y, Kuzmin A, Hua Y, Zhao J, Xu S, et al. Next generation lanthanide doped nanoscintillators and photon converters. eLight. 2022;2:1–24.
Bulin A-L, Vasil’ev A, Belsky A, Amans D, Ledoux G, Dujardin C. Modelling energy deposition in nanoscintillators to predict the efficiency of the X-ray-induced photodynamic effect. Nanoscale. 2015;7:5744–51.
Yu X, Liu X, Wu W, Yang K, Mao R, Ahmad F, et al. CT/MRI-guided synergistic radiotherapy and X-ray inducible photodynamic therapy using Tb-doped Gd-W-nanoscintillators. Angew Chem. 2019;131:2039–44.
Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv Mater. 2017;29:1–26.
Shen S, Jiang D, Cheng L, Chao Y, Nie K, Dong Z, et al. Renal-clearable ultrasmall coordination polymer nanodots for chelator-free 64Cu-labeling and imaging-guided enhanced radiotherapy of cancer. ACS Nano. 2017;11:9103–11.
Zhang XD, Chen J, Min Y, Park GB, Shen X, Song SS, et al. Metabolizable Bi2Se3 nanoplates: biodistribution, toxicity, and uses for cancer radiation therapy and imaging. Adv Funct Mater. 2014;24:1718–29.
Gong T, Li Y, Lv B, Wang H, Liu Y, Yang W, et al. Full-process radiosensitization based on nanoscale metal-organic frameworks. ACS Nano. 2020;14:3032–40.
Yang B, Chen Y, Shi J. Reactive oxygen species (ROS)-based nanomedicine. Chem Rev. 2019;119:4881–985.
Kirsanova DY, Gadzhimagomedova ZM, Maksimov AY, Soldatov AV. Nanomaterials for deep tumor treatment. Mini Rev Med Chem. 2021;21:677–88.
Popovich K, Procházková L, Pelikánová IT, Vlk M, Palkovský M, Jarý V, et al. Preliminary study on singlet oxygen production using CeF3:Tb3+@SiO2-PpIX. Radiat Meas. 2016;90:325–8.
Zhang Q, Guo X, Cheng Y, Chudal L, Pandey NK, Zhang J, et al. Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment. Signal Transduct Target Ther. 2020;5:4–6.
Ma L, Zou X, Chen W. A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol. 2014;10:1501–8.
Ma L, Zou X, Bui B, Chen W, Song KH, Solberg T. X-ray excited ZnS:Cu, Co afterglow nanoparticles for photodynamic activation. Appl Phys Lett. 2014;105: 013702.
Gadzhimagomedova Z, Zolotukhin P, Kit O, Kirsanova D, Soldatov A. Nanocomposites for X-ray photodynamic therapy. Int J Mol Sci. 2020;21:1–15.
Sengar P, Garcia-Tapia K, Chauhan K, Jain A, Juarez-Moreno K, Borbón-Nuñez HA, et al. Dualphotosensitizer coupled nanoscintillator capable of producing type I and type II ROS for next generation photodynamic therapy. J Colloid Interface Sci. 2019;536:586–97.
Zhang W, Zhang X, Shen Y, Shi F, Song C, Liu T, et al. Ultra-high FRET efficiency NaGdF4: Tb3+-Rose Bengal biocompatible nanocomposite for X-ray excited photodynamic therapy application. Biomaterials. 2018;184:31–40.
Chen MH, Jenh YJ, Wu SK, Chen YS, Hanagata N, Lin FH. Non-invasive photodynamic therapy in brain cancer by use of Tb3+-doped LaF3 nanoparticles in combination with photosensitizer through X-ray irradiation: a proof-of-concept study. Nanoscale Res Lett. 2017;12:1–6.
Elmenoufy AH, Tang Y, Hu J, Xu H, Yang X. A novel deep photodynamic therapy modality combined with CT imaging established via X-ray stimulated silica-modified lanthanide scintillating nanoparticles. Chem Commun. 2015;51:12247–50.
Bulin A-L, Truillet C, Chouikrat R, Lux F, Frochot C, Amans D, et al. X-ray-induced singlet oxygen activation with nanoscintillator-coupled porphyrins. J Phys Chem C. 2013;117:21583–9.
Kaščáková S, Giuliani A, Lacerda S, Pallier A, Mercère P, Tóth É, et al. X-ray-induced radiophotodynamic therapy (RPDT) using lanthanide micelles: beyond depth limitations. Nano Res. 2015;8:2373–9.
Zhang X, Lan B, Wang S, Gao P, Liu T, Rong J, et al. Low-dose X-ray excited photodynamic therapy based on NaLuF4:Tb3+-Rose Bengal nanocomposite. Bioconjug Chem. 2019;30:2191–200.
Popovich K, Tomanová K, Čuba V, Procházková L, Pelikánová IT, Jakubec I, et al. LuAG:Pr3+-porphyrin based nanohybrid system for singlet oxygen production: toward the next generation of PDTX drugs. J Photochem Photobiol B. 2018;179:149–55.
Procházková L, Pelikánová IT, Mihóková E, Dědic R, Čuba V. Novel scintillating nanocomposite for X-ray induced photodynamic therapy. Radiat Meas. 2019;121:13–7.
Procházková L, Čuba V, Beitlerová A, Jarý V, Omelkov S, Nikl M. Ultrafast Zn(Cd, Mg)O: Ga nanoscintillators with luminescence tunable by band gap modulation. Opt Express. 2018;26:29482–94.
Wang GD, Nguyen HT, Chen H, Cox PB, Wang L, Nagata K, et al. X-ray induced photodynamic therapy: a combination of radiotherapy and photodynamic therapy. Theranostics. 2016;6:2295–305.
Bekah D, Cooper D, Kudinov K, Hill C, Seuntjens J, Bradforth S, et al. Synthesis and characterization of biologically stable, doped LaF3 nanoparticles co-conjugated to PEG and photosensitizers. J Photochem Photobiol A Chem. 2016;329:26–34.
Zou X, Yao M, Ma L, Hossu M, Han X, Juzenas P, et al. X-ray-induced nanoparticle-based photodynamic therapy of cancer. Nanomedicine. 2014;9:2339–51.
Sapre AA, Novitskaya E, Vakharia V, Cota A, Wrasidlo W, Hanrahan SM, et al. Optimized scintillator YAG: Pr nanoparticles for X-ray inducible photodynamic therapy. Mater Lett. 2018;228:49–52.
Kaszewski J, Olszewski J, Rosowska J, Witkowski B, Wachnicki Ł, Wenelska K, et al. HfO2: Eu nanoparticles excited by X-rays and UV-visible radiation used in biological imaging. J Rare Earths. 2019;37:1176–82.
Li X, Xue Z, Jiang M, Li Y, Zeng S, Liu H. Soft X-ray activated NaYF4:Gd/Tb scintillating nanorods for in vivo dual-modal X-ray/X-ray-induced optical bioimaging. Nanoscale. 2018;10:342–50.
Generalov R, Kuan WB, Chen W, Kristensen S, Juzenas P. Radiosensitizing effect of zinc oxide and silica nanocomposites on cancer cells. Colloids Surf B Biointerfaces. 2015;129:79–86.
Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022;8:1–10.
Perou CM, Sorlie T, Eisen MB, Van De RM, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;533:747–52.
Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2019;173:291–304.
Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, et al. Event-free survival with pembrolizumab in early triple-negative breast cancer. N Engl J Med. 2022;386:556–67.
Wang X, Sun W, Shi H, Ma H, Niu G, Li Y, et al. Organic phosphorescent nanoscintillator for low-dose X-ray-induced photodynamic therapy. Nat Commun. 2022;13:1–9.
Zhang B, Liu H, Wang Y, Zhang Y, Cheng J. Application of singlet oxygen-activatable nanocarriers to boost X-ray-induced photodynamic therapy and cascaded ferroptosis for breast cancer treatment. J Mater Chem B. 2023;11:9685–96.
Jain A, Koyani R, Muñoz C, Sengar P, Contreras OE, Juárez P, et al. Magnetic-luminescent cerium-doped gadolinium aluminum garnet nanoparticles for simultaneous imaging and photodynamic therapy of cancer cells. J Colloid Interface Sci. 2018;526:220–9.
Maiti D, Yu H, Kim BS, Naito M, Yamashita S, Kim HJ, et al. Rose Bengal decorated NaYF4: Tb nanoparticles for low dose X-ray-induced photodynamic therapy in cancer cells. ACS Appl Bio Mater. 2022;5:5477–86.
Maiti D, Yu H, Mochida Y, Won S, Yamashita S, Naito M, et al. Terbium-Rose Bengal coordination nanocrystals-induced ROS production under low-dose X-rays in cultured cancer cells for photodynamic therapy. ACS Appl Bio Mater. 2023;6:2505–13.
Chen X, Liu J, Li Y, Pandey NK, Chen T, Wang L, et al. Study of copper-cysteamine based X-ray induced photodynamic therapy and its effects on cancer cell proliferation and migration in a clinical mimic setting. Bioact Mater. 2022;7:504–14.
Zhang B, Xue R, Lyu J, Gao A, Sun C. Tumor acidity/redox hierarchical-activable nanoparticles for precise combination of X-ray-induced photodynamic therapy and hypoxia-activated chemotherapy. J Mater Chem B. 2022;10:3849–60.
Sengar P, Juárez P, Meza AV, Arellano DL, Jain A, Chauhan K, et al. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy. J Nanobiotechnol. 2018;16:1–19.
Jiang F, Lee C, Zhang W, Jiang W, Cao Z, Chong HB, et al. Radiodynamic therapy with CsI(na)@MgO nanoparticles and 5-aminolevulinic acid. J Nanobiotechno. 2022;20:1–15.
Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450–62.
Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7:448–58.
Sia D, Villanueva A, Friedman SL, Llovet JM. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 2017;152:745–61.
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.
Cao J, Wang J, He C, Fang M. Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res. 2019;9:2303–13.
Fitzmaurice C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683–91.
Celsa C, Stornello C, Giuffrida P, Giacchetto CM, Grova M, Rancatore G, et al. Direct-acting antiviral agents and risk of Hepatocellular carcinoma: critical appraisal of the evidence. Ann Hepatol. 2022;27: 100568.
Zhen X, Pandey NK, Amador E, Hu W, Liu B, Nong W, et al. Potassium iodide enhances the anti-hepatocellular carcinoma effect of copper-cysteamine nanoparticle mediated photodynamic therapy on cancer treatment. Mater Today Phys. 2022;27: 100838.
Vasuri F, Renzulli M, Fittipaldi S, Brocchi S, Clemente A, Cappabianca S, et al. Pathobiological and radiological approach for hepatocellular carcinoma subclassification. Sci Rep. 2019;9:1–10.
Mushtaq A, Iqbal MZ, Kong X. Antiviral effects of coinage metal-based nanomaterials to combat COVID-19 and its variants. J Mater Chem B. 2022;10:5323–43.
Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. The Lancet. 2021;398:535–54.
Araujo LH, Horn L, Merritt RE, Shilo K, Xu-Welliver M, Carbone DP. 69—Cancer of the lung: non-small cell lung cancer and small cell lung cancer. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, editors. Abeloff’s clinical oncology. Amsterdam: Elsevier; 2020.
Jiang Y, Su Z, Liang H, Liu J, Liang W, He J. Video-assisted thoracoscopy for lung cancer: Who is the future of thoracic surgery? J Thorac Dis. 2020;12:4427–33.
Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol. 2016;11:1–14.
Yang CC, Wang WY, Lin FH, Hou CH. Rare-earth-doped calcium carbonate exposed to X-ray irradiation to induce reactive oxygen species for tumor treatment. Int J Mol Sci. 2019;20:1148.
Herbst RS, Baas P, Kim DW, Felip E, Pérez-Gracia JL, Han JY, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. The Lancet. 2016;387:1540–50.
Chen H, Sun X, Wang GD, Nagata K, Hao Z, Wang A, et al. LiGa5O8:Cr-based theranostic nanoparticles for imaging-guided X-ray induced photodynamic therapy of deep-seated tumors. Mater Horiz. 2017;4:1092–101.
Rossi F, Bedogni E, Bigi F, Rimoldi T, Cristofolini L, Pinelli S, et al. Porphyrin conjugated SiC/SiOx nanowires for X-ray-excited photodynamic therapy. Sci Rep. 2015;5:1–6.
Yang DM, Cvetkovic D, Chen L, Ma CMC. Therapeutic effects of in-vivo radiodynamic therapy (RDT) for lung cancer treatment: a combination of 15 MV photons and 5-aminolevulinic acid (5-ALA). Biomed Phys Eng Express. 2022;8: 065031.
Sanchez G, Nova J, Rodriguez-Hernandez AE, Solorzano-Restrepo C, Gonzalez J, Olmos M, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database Syst Rev. 2016;2016:1–32.
Domingues B, Lopes JM, Soares P, Pópulo H. Melanoma treatment in review. Immunotargets Ther. 2018;7:35–49.
Hu W, Fang L, Ni R, Zhang H, Pan G. Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer. 2022;22:1–11.
Shi L, Liu P, Wu J, Ma L, Zheng H, Antosh MP, et al. The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma. Nanomedicine. 2019;14:2027–43.
Ma L, Chen W, Schatte G, Wang W, Joly AG, Huang Y, et al. A new Cu-cysteamine complex: structure and optical properties. J Mater Chem C Mater. 2014;2:4239–46.
Pandey NK, Chudal L, Phan J, Lin L, Johnson O, Xing M, et al. A facile method for the synthesis of copper-cysteamine nanoparticles and study of ROS production for cancer treatment. J Mater Chem B. 2019;7:6630–42.
Takahashi J, Murakami M, Mori T, Iwahashi H. Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model. Sci Rep. 2018;8:1–9.
Hasegawa T, Takahashi J, Nagasawa S, Doi M, Moriyama A, Iwahashi H. Dna strand break properties of protoporphyrin IX by X-ray irradiation against melanoma. Int J Mol Sci. 2020;21:2302.
Mármol I, Sánchez-de-Diego C, Dieste AP, Cerrada E, Yoldi MJR. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18:197.
Sameer AS. Colorectal cancer: molecular mutations and polymorphisms. Front Oncol. 2013;3:114.
Stintzing S. Management of colorectal cancer. Prime Rep. 2014;6:108.
Sang R, Deng F, Engel A, Goldys E, Deng W. Lipid-polymer nanocarrier platform enables X-ray induced photodynamic therapy against human colorectal cancer cells. Biomed Pharmacother. 2022;155: 113837.
Lan G, Ni K, Xu R, Lu K, Lin Z, Chan C, et al. Nanoscale metal–organic layers for deeply penetrating X-ray-induced photodynamic therapy. Angew Chem. 2017;56:12102–6.
Deng W, McKelvey KJ, Guller A, Fayzullin A, Campbell JM, Clement S, et al. Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Cent Sci. 2020;6:715–26.
